Organon to pay Vermont $75,455 to resolve marketing allegations involving antidepressants

-A A +A

Organon to pay Vermont $75,455 to resolve marketing allegations involving antidepressants

Fri, 10/17/2014 - 10:22am -- tim

Vermont will receive $75,455 in restitution and other recoveries as its share of a national $31 million civil settlement with Organon Pharmaceuticals USA Inc to resolve allegations that the drug manufacturer, which is now owned by Merck & Co, Inc, engaged in various marketing violations. Specifically, whistleblowers in two federal lawsuits filed in Massachusetts and Texas alleged that Organon underpaid rebates and misrepresented drug prices to state Medicaid programs, offered improper financial incentives to nursing home pharmacy companies, and promoted its antidepressants Remeron and Remeron SolTab for unapproved uses in children and adolescents. The lawsuits were filed under the federal False Claims Act and various State false claims statutes.

Vermont AG: Oct 17, 2014